GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYESW) » Definitions » Forward PE Ratio

EYESW (Second Sight Medical Products) Forward PE Ratio : 0.00 (As of Apr. 14, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Second Sight Medical Products Forward PE Ratio?

Second Sight Medical Products's Forward PE Ratio for today is 0.00.

Second Sight Medical Products's PE Ratio without NRI for today is 0.00.

Second Sight Medical Products's PE Ratio (TTM) for today is 0.00.


Second Sight Medical Products Forward PE Ratio Historical Data

The historical data trend for Second Sight Medical Products's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products Forward PE Ratio Chart

Second Sight Medical Products Annual Data
Trend
Forward PE Ratio

Second Sight Medical Products Quarterly Data
Forward PE Ratio

Competitive Comparison of Second Sight Medical Products's Forward PE Ratio

For the Medical Devices subindustry, Second Sight Medical Products's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Second Sight Medical Products's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Second Sight Medical Products's Forward PE Ratio falls into.


;
;

Second Sight Medical Products Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Second Sight Medical Products  (NAS:EYESW) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Second Sight Medical Products Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Second Sight Medical Products's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Second Sight Medical Products Business Description

Traded in Other Exchanges
N/A
Address
13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.

Second Sight Medical Products Headlines

From GuruFocus

Second Sight Reports Fourth Quarter 2018 Business Update

By Marketwired Marketwired 01-07-2019

Second Sight Medical Products Announces Closing of Public Offering

By Business Wire Business Wire 06-25-2021

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

By Business Wire Business Wire 08-31-2022